Business Description
Edap TMS SA
NAICS : 334510
SIC : 3845
ISIN : US2683111072
Share Class Description:
EDAP: ADRCompare
Compare
Traded in other countries / regions
EDAP.USAEDA.Germany IPO Date
1997-08-01Description
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its global activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.16 | |||||
| Equity-to-Asset | 0.62 | |||||
| Debt-to-Equity | 0.15 | |||||
| Debt-to-EBITDA | -0.42 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 3.85 | |||||
| Beneish M-Score | -2.5 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 0.8 | |||||
| 3-Year EPS without NRI Growth Rate | -163 | |||||
| 3-Year Book Growth Rate | 15.2 | |||||
| Future 3-5Y Total Revenue Growth Rate | 13.26 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 22.46 | |||||
| 9-Day RSI | 34.54 | |||||
| 14-Day RSI | 42.29 | |||||
| 6-1 Month Momentum % | 14.22 | |||||
| 12-1 Month Momentum % | -29.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.84 | |||||
| Quick Ratio | 2.3 | |||||
| Cash Ratio | 1.58 | |||||
| Days Inventory | 137.28 | |||||
| Days Sales Outstanding | 98.4 | |||||
| Days Payable | 121.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -8.4 | |||||
| Shareholder Yield % | 0.56 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 40.42 | |||||
| Operating Margin % | -32.68 | |||||
| Net Margin % | -34.99 | |||||
| FCF Margin % | -31.43 | |||||
| ROE % | -33.34 | |||||
| ROA % | -22.04 | |||||
| ROIC % | -73.26 | |||||
| ROC (Joel Greenblatt) % | -130.46 | |||||
| ROCE % | -28.64 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.11 | |||||
| PB Ratio | 4.35 | |||||
| Price-to-Tangible-Book | 4.62 | |||||
| EV-to-EBIT | -10.58 | |||||
| EV-to-EBITDA | -10.58 | |||||
| EV-to-Revenue | 3.54 | |||||
| EV-to-Forward-Revenue | 3.24 | |||||
| EV-to-FCF | -11.13 | |||||
| Price-to-Projected-FCF | 18.62 | |||||
| Price-to-Median-PS-Value | 1.67 | |||||
| Price-to-Net-Current-Asset-Value | 5.63 | |||||
| Price-to-Net-Cash | 27.92 | |||||
| Earnings Yield (Greenblatt) % | -9.45 | |||||
| FCF Yield % | -7.61 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers